User:kobisxhf870105

Gemtuzumab Ozogamicin treatment represents a important development in the treatment of aggressive leukemic cancer, mainly acute myeloid cancer (AML). This agent combines a monoclonal protein

https://www.targetmol.com/compound/gemtuzumab